Pearsanta initiates study of blood test for early endometriosis detection
Aditxt subsidiary Pearsanta has started enrolment in a clinical trial to assess the blood-based Mitomic Endometriosis Test (MET), aimed at…
Aditxt subsidiary Pearsanta has started enrolment in a clinical trial to assess the blood-based Mitomic Endometriosis Test (MET), aimed at…
Breast cancer is the most diagnosed cancer in women worldwide. During October, breast cancer awareness month, community outreach should be…
Color Health, in collaboration with Google Cloud, has unveiled an initiative aimed at increasing the accessibility of breast cancer screening.…
Natera has announced the initiation of the Phase II TEODOR trial of its Signatera test aimed at replacing chemotherapy with…
Proteomics International Laboratories has secured a patent from the Japan Patent Office for PromarkerEndo, its diagnostic blood test for endometriosis,…
The US Food and Drug Administration (FDA) has secured approval to Teal Health’s at-home vaginal sample self-collection device, Teal Wand,…
University of South Australia (UniSA) researcher Dr Amanda Lumsden and a transdisciplinary team are jointly designing an ovarian cancer symptom assessment…
iCAD has partnered with Microsoft to incorporate a suite of AI-powered mammography solutions into its ProFound Breast Health Suite on…
The landscape of contraception for women has seen minimal change over the past 50 years, with successive generations often relying…
Aditxt subsidiary Pearsanta has secured approval from WCG Clinical’s Institutional Review Board (IRB) to begin a clinical trial of the…